Nobiletin
Specifically for Cellular Aging
0 up • 0 down
Why it works for Cellular Aging:
Circadian-clock activation (via RORα/γ): Nobiletin is a clock-amplitude enhancer that directly targets RORα/γ in the circadian oscillator. In animals and cells, this strengthens circadian rhythms tied to metabolism and cellular stress responses—processes closely linked to aging biology. Cell
Mitochondrial support & bioenergetics: In mice under metabolic challenge, nobiletin improves skeletal-muscle mitochondrial respiration and supercomplex organization—mechanisms relevant to age-related metabolic decline. Nature
Senescence/senomorphic effects (cell models): In a D-galactose cellular aging model (C2C12 myoblasts), nobiletin reduced SA-β-gal positivity and senescence markers (p16/p21/p53), restored mitochondrial function, and upregulated AMPK-autophagy signaling. (Note: this is in vitro.) MDPI
Clock–aging link (context): Aging commonly weakens circadian outputs; interventions that bolster clock amplitude can preserve cellular homeostasis. Nobiletin leverages this axis. SpringerLink
How to use for Cellular Aging:
Studied oral dose (human RCT, different indication): A mixture of nobiletin + tangeretin (NoT) 50 mg once daily for 6 weeks was used in a randomized, placebo-controlled crossover trial for nocturia; it improved nighttime voids without notable adverse events. This gives a sense of human exposure used in trials, though it does not validate anti-aging efficacy. MDPI
Timing (preclinical chrono-nutrition insight): In mice, a single 100 mg/kg dose shifted peripheral clocks; dosing at the beginning of the active period boosted amplitude more than other times. If timing is translated at all, that suggests morning/active-phase dosing could make more sense than bedtime—but this is animal data only. MDPI
With food / formulation: Nobiletin is poorly water-soluble with low oral bioavailability; lipid/emulsion and protein-stabilized Pickering emulsions significantly improve bioaccessibility and in-vivo exposure in animals. Practically, users often take it with a meal containing fat or choose enhanced-bioavailability formulations (emulsions/nano-formulations). (Evidence base: formulation studies, not clinical outcomes.) SpringerLink
Scientific Evidence for Cellular Aging:
Clock & metabolic protection (mechanism → organism):
• Cell Metabolism 2016: Identified nobiletin as a RORα/γ-targeting circadian enhancer that protects against metabolic syndrome in mice. Cell
• Nature Communications 2019: Demonstrated improved mitochondrial respiration and metabolic health in mice under high-fat stress, linking circadian strengthening to healthier aging physiology. Nature
Cellular aging model:
• Int J Mol Sci 2022: In D-galactose–aged myoblasts, nobiletin reduced senescence markers and rescued mitochondrial/autophagy pathways. (In vitro.) MDPI
Human data (not cellular aging endpoints):
• J Clin Med 2023: Nocturia RCT using 50 mg/day NoT showed symptom benefit and acceptable short-term safety. This supports tolerability at studied doses, not anti-aging efficacy. MDPI
Reviews (mechanistic integration):
• Peer-reviewed reviews summarize nobiletin’s clock-targeting actions and potential for healthy aging, while emphasizing the gap in human aging trials. Europe PMC
Specific Warnings for Cellular Aging:
Drug–drug interaction potential (CYPs): Polymethoxyflavones in citrus (nobiletin/tangeretin/sinensetin) can alter CYP1A2 and CYP3A4 activity in vitro/food-matrix studies, implying possible interactions with drugs metabolized by these enzymes (e.g., some anticoagulants, statins, CCBs, immunosuppressants). Caution and medication review are prudent. LAUSR
Herb–herb interactions: Co-administration with anemarsaponin BII (herbal component) increased systemic exposure to nobiletin via CYP3A4/P-gp pathways in a PK study—flagging that combinations can meaningfully shift levels. Taylor & Francis Online
Hormonal effects at high doses (preclinical): In mice, high-dose nobiletin acutely stimulated corticosterone and adrenaline and modulated peripheral clocks, potentially via PDE4 inhibition. Human relevance and chronic dosing effects are unknown. MDPI
Bioavailability & product variability: Because native nobiletin is poorly bioavailable, formulation differences (emulsions/nano-dispersions) can change exposure several-fold—meaning two products with the same “mg” may not be equivalent. ScienceDirect
Population precautions: Absent robust human aging trials, use caution in pregnancy/lactation, significant liver disease, or polypharmacy; review for CYP-mediated interactions using reputable tables (e.g., Flockhart) if taking other narrow-therapeutic-index meds. Indiana University School of Medicine
General: Nobiletin is not an approved therapy for aging. Discuss with a clinician before starting; monitor for GI upset, headache, sleep changes, or unusual symptoms. (Safety datasets are still relatively small.)
General Information (All Ailments)
What It Is
Chemical identity / source
- Nobiletin is a polymethoxyflavone (a type of flavonoid) with six methoxy (–OCH₃) groups; its full IUPAC name is 3′,4′,5,6,7,8-hexamethoxyflavone (or sometimes referenced in the 2-phenylchromen-4-one series).
- It is naturally found in the peels of citrus fruits (especially certain mandarins, oranges, and related species).
Physical / chemical properties
- Because of its multiple methoxy groups, nobiletin is relatively lipophilic (fat-soluble), which aids membrane penetration but presents challenges in aqueous solubility and bioavailability.
- In the body, it undergoes metabolism (especially demethylation by cytochrome P450 enzymes) to produce metabolites (notably 4′-demethylated nobiletin) that may themselves be bioactive.
Pharmacokinetics / distribution
- After oral ingestion, nobiletin is absorbed in the intestine (likely via passive permeability or proton-linked transport mechanisms) and then subject to first-pass metabolism.
- Studies show that nobiletin (or its metabolites) can reach the brain, crossing the blood-brain barrier, with brain half-life longer than in plasma. BioMed Central
- Its bioavailability is limited, and various formulation strategies (nanoemulsions, solid dispersions, etc.) have been explored to enhance its absorption and tissue delivery.
How It Works (Mechanisms of Action)
Nobiletin appears to influence many biological pathways. The multiplicity of effects is both a promise and a complication (i.e. pleiotropy). Below are some of the proposed and observed mechanisms from in vitro and animal studies:
Anti-oxidant / radical scavenging effects
- Nobiletin can neutralize reactive oxygen species (ROS) and reactive nitrogen species, reducing oxidative stress. Its structural groups (particularly methoxy groups) enable it to scavenge free radicals.
- It may also upregulate endogenous antioxidant defenses (e.g. via Nrf2 / antioxidant response elements) in some contexts. ScienceDirect
Anti-inflammatory / immunomodulation
- Nobiletin has been observed to inhibit inflammatory signaling cascades, such as NF-κB, reduce expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and suppress proinflammatory cytokines (TNF-α, IL-6, etc.) in cellular and animal models. Drugs.com
- It also modulates upstream receptors or adaptor pathways (e.g. TLR4) and associated kinases to blunt inflammatory responses. MDPI
Metabolic regulation / insulin sensitivity
- In animal and cellular models, nobiletin improves glucose tolerance, lowers insulin resistance, and can reduce hepatic steatosis (fat accumulation in the liver). MDPI
- It influences lipid metabolism (cholesterol, triglycerides) and the expression of lipid regulatory genes (e.g. via PPARs, SREBPs) in liver and adipose tissue. ScienceDirect
- It may activate AMPK (AMP-activated protein kinase), a central energy sensor, which can drive beneficial changes in metabolic pathways (glucose uptake, fatty acid oxidation). salispharm.com
Neuroprotection / cognitive effects
- Nobiletin exerts protective effects in various neurological and neurodegenerative models. For example, it can reduce neuroinflammation and oxidative stress, inhibit apoptosis of neurons, enhance synaptic plasticity, and modulate pathways like cAMP/PKA/ERK/CREB that support memory formation. BioMed Central
- In Alzheimer’s disease–type models, nobiletin may inhibit β-secretase (BACE1) activity, reduce amyloid-β production, and promote clearance mechanisms (e.g. via neprilysin). BioMed Central
- It can also affect the expression of synaptic receptors (e.g. AMPA receptor phosphorylation) and promote neuronal survival.
Circadian regulation / mitochondrial energetics
- More recently, nobiletin has been shown to influence circadian clock genes (e.g. RORs) and mitochondrial respiration in skeletal muscle, potentially aligning metabolic function with biological rhythms and improving energy efficiency. BioMed Central
- By enhancing mitochondrial function and reducing metabolic “inefficiencies,” it may help in age-related metabolic decline. BioMed Central
Anti-cancer / anti-proliferative effects
- In multiple cancer cell lines and animal tumor models, nobiletin has shown inhibition of cell proliferation, induction of cell cycle arrest and apoptosis, inhibition of angiogenesis, suppression of metastasis, and modulation of oncogenic signaling (e.g. NF-κB, EMT, PI3K/Akt) pathways. Drugs.com
- It can act synergistically with other compounds (e.g. statins) in cancer prevention models. Wikipedia
Bone health / anti-osteoporosis effects
- Some animal studies suggest that nobiletin can suppress osteoclastogenesis (the bone-resorbing cells), reduce bone loss, and thereby could have relevance in osteoporosis or arthritis models. Drugs.com
Thus, nobiletin acts via a network of pathways rather than a single “magic bullet” mechanism.
Why It’s Important / Potential Benefits
Given its multifaceted biological effects, nobiletin is of interest in various health domains:
Metabolic syndrome, diabetes, cardiovascular risk
- Because it can improve insulin sensitivity, reduce hepatic fat accumulation, and favorably modulate lipid profiles, nobiletin may have value in preventing or mitigating type 2 diabetes, nonalcoholic fatty liver disease, dyslipidemia, and related cardiovascular risks. MDPI
- In diabetic animal models, nobiletin improved hemodynamics (blood pressure, heart function) and myocardial metrics. Drugs.com
Neurodegenerative diseases and cognitive aging
- Its neuroprotective, anti-inflammatory, and synaptic enhancement effects make nobiletin a promising molecule in the context of Alzheimer’s disease, Parkinson’s disease, age-related cognitive decline, and memory disorders. BioMed Central
- One small human trial combining nobiletin with another agent (perilla seed oil) in older adults found some stabilization or improvement in cognitive measures vs control. Drugs.com
Cancer prevention / adjunct therapy
- Because nobiletin can inhibit tumor-promoting pathways, suppress inflammation, and induce apoptosis in cancer cells, it is studied as a possible chemopreventive agent or adjunct to conventional therapies. Drugs.com
Anti-inflammatory / general cell protection
- Chronic, low-level inflammation underlies many chronic diseases (atherosclerosis, metabolic syndrome, neurodegeneration). Nobiletin’s ability to temper inflammatory signaling may contribute to “healthspan” benefits. ScienceDirect
- By protecting cells against oxidative stress, nobiletin may help preserve tissue integrity over time.
Bone and musculoskeletal health
- If its anti-osteoclast and bone-preservation effects are validated in humans, nobiletin may help in osteoporosis, bone loss, or joint health contexts. Drugs.com
Aging / longevity
- Because many of its effects (metabolic optimization, anti-inflammation, mitochondrial support, circadian alignment) intersect with mechanisms of aging, some researchers consider nobiletin a candidate for nutraceutical approaches to healthspan extension. MDPI
However, it is very important to emphasize: none of these potential benefits are yet established in humans via robust clinical trials. The promising signals come heavily from cells, rodents, and limited pilot human work.
Considerations / Cautions / Unknowns
When evaluating nobiletin’s potential as a health-targeted supplement or therapeutic, several caveats and unknowns must be kept in mind:
Lack of large-scale human clinical trials
- As of now, no well-powered, randomized, placebo-controlled trials have been published that definitively establish safety, optimal dosing, efficacy, or long-term effects of nobiletin alone in humans. Drugs.com
- The one human trial cited combined nobiletin with another compound, making it hard to isolate the effect of nobiletin alone. Drugs.com
Bioavailability and dosing challenges
- Because of its lipophilicity and sometimes low aqueous solubility, absorption in humans is limited. There’s uncertainty regarding what dose is needed to achieve tissue levels seen in animal studies. ScienceDirect
- Formulation strategies (nanoemulsions, solid dispersions, encapsulation) may improve delivery but add complexity and variability. ScienceDirect+1
Metabolism / interactions
- Because nobiletin is metabolized by liver cytochrome P450 enzymes (via demethylation), there is potential for drug–flavonoid interactions (e.g. affecting levels of co-administered drugs metabolized by CYPs). BioMed Central
- Interactions with other dietary flavonoids or supplements may modulate its effects in unpredictable ways.
Safety / toxicity
- To date, there is limited data on long-term safety in humans. In animal studies, high doses over periods have not shown dramatic toxicity, changes in organ weights, behavior, or overt adverse effects in many cases. MDPI
- However, absence of evidence is not evidence of absence. Potential unknown adverse effects (e.g. genotoxicity, liver stress, idiosyncratic toxicity) remain a concern.
Dose, standardization, and purity
- Because it is a natural phytochemical, supplement preparations may vary widely in purity, dosage, and presence of contaminants. Without regulation, batches might not deliver what is claimed. Biomedicus
- The “right” dose to produce beneficial effects without harm is not established in humans.
Translatability from animal models
- Many observed effects exist in rodents or cell cultures under controlled conditions; human physiology is more complex. What works in mice may not translate to humans in terms of magnitude, safety, or feasibility.
Possible off-target / paradoxical effects
- Because nobiletin modulates multiple pathways, in certain disease states or in combination with certain medications, its effects might be maladaptive or interfere with other interventions. For example, in one UV radiation study, nobiletin protected cells from UVB but worsened the effects of UVA in some cells. Drugs.com
Regulatory status
- Depending on jurisdiction, nobiletin might be sold as a “dietary supplement,” “nutraceutical,” or undergo stricter regulation if claimed to treat disease. Its status, permissible claims, quality controls, and testing requirements vary.
Helps with these conditions
Nobiletin is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Type 2 Diabetes
Circadian-clock modulation (ROR agonist): Nobiletin acts on the body’s molecular clock (enhancing ROR activity), which in turn regulates glucose and l...
Oxidative Stress
Multi-pathway antioxidant + anti-inflammatory actions (cell/animal data, mechanistic reviews):Upregulates endogenous antioxidant defenses (Nrf2/ARE ax...
Cellular Aging
Circadian-clock activation (via RORα/γ): Nobiletin is a clock-amplitude enhancer that directly targets RORα/γ in the circadian oscillator. In animals...
Community Discussion
Share results, tips, and questions about Nobiletin.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Cellular Aging
Talk specifically about using Nobiletin for Cellular Aging.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.